Literature DB >> 17965741

The peripheral cannabinoid receptor knockout mice: an update.

N E Buckley1.   

Abstract

This review gives an overview of the CB2 receptor (CB2R) knockout (CB2R-/-) mice phenotype and the work that has been carried out using this mutant mouse. Using the CB2R-/- mice, investigators have discovered the involvement of CB2R on immune cell function and development, infection, embryonic development, bone loss, liver disorders, pain, autoimmune inflammation, allergic dermatitis, atherosclerosis, apoptosis and chemotaxis. Using the CB2R-/- mice, investigators have also found that this receptor is not involved in cannabinoid-induced hypotension. In addition, the CB2R-/- mice have been used to determine specific tissue CB2R expression. The specificity of synthetic cannabinoid agonists, antagonists and anti-CB2R antibodies has been screened using tissues from CB2R-/- mice. Thus, the use of this mouse model has greatly helped reveal the diverse events involving the CB2R, and has aided in drug and antibody screening.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965741      PMCID: PMC2219525          DOI: 10.1038/sj.bjp.0707527

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  85 in total

1.  Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat.

Authors:  N E Buckley; S Hansson; G Harta; E Mezey
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

2.  Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.

Authors:  Z M Yang; B C Paria; S K Dey
Journal:  Biol Reprod       Date:  1996-10       Impact factor: 4.285

3.  Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein.

Authors:  S J Hardwick; L Hegyi; K Clare; N S Law; K L Carpenter; M J Mitchinson; J N Skepper
Journal:  J Pathol       Date:  1996-07       Impact factor: 7.996

4.  Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.

Authors:  Y Ouyang; S G Hwang; S H Han; N E Kaminski
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

5.  Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

Authors:  D Shire; B Calandra; M Rinaldi-Carmona; D Oustric; B Pessègue; O Bonnin-Cabanne; G Le Fur; D Caput; P Ferrara
Journal:  Biochim Biophys Acta       Date:  1996-06-07

6.  Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.

Authors:  J A Wagner; K Varga; E F Ellis; B A Rzigalinski; B R Martin; G Kunos
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

7.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

Authors:  A R Schatz; M Lee; R B Condie; J T Pulaski; N E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  1997-02       Impact factor: 4.219

8.  Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.

Authors:  K Varga; J A Wagner; D T Bridgen; G Kunos
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

9.  Isolation and characterization of osteoblast precursor cells from human bone marrow.

Authors:  D J Rickard; M Kassem; T E Hefferan; G Sarkar; T C Spelsberg; B L Riggs
Journal:  J Bone Miner Res       Date:  1996-03       Impact factor: 6.741

10.  Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1.

Authors:  W Zhu; H Friedman; T W Klein
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

View more
  56 in total

1.  Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.

Authors:  Hai-Ying Zhang; Ming Gao; Qing-Rong Liu; Guo-Hua Bi; Xia Li; Hong-Ju Yang; Eliot L Gardner; Jie Wu; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats.

Authors:  Tian-Shui Yu; Zi-Hui Cheng; Li-Qiang Li; Rui Zhao; Yan-Yan Fan; Yu Du; Wen-Xiang Ma; Da-Wei Guan
Journal:  Int J Legal Med       Date:  2010-06-11       Impact factor: 2.686

3.  Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses.

Authors:  Sreemanti Basu; Avijit Ray; Bonnie N Dittel
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

4.  Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.

Authors:  Q-R Liu; C-H Pan; A Hishimoto; C-Y Li; Z-X Xi; A Llorente-Berzal; M-P Viveros; H Ishiguro; T Arinami; E S Onaivi; G R Uhl
Journal:  Genes Brain Behav       Date:  2009-06-03       Impact factor: 3.449

Review 5.  Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.

Authors:  Guy A Cabral; LaToya Griffin-Thomas
Journal:  Expert Rev Mol Med       Date:  2009-01-20       Impact factor: 5.600

Review 6.  Targeting the endocannabinoid system in Alzheimer's disease.

Authors:  Jeremy Koppel; Peter Davies
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

7.  Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.

Authors:  Christine Börner; Michal Smida; Volker Höllt; Burkhart Schraven; Jürgen Kraus
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1 /CB2 versus GPR55 receptors.

Authors:  Xiao-Fei Wang; Ewa Galaj; Guo-Hua Bi; Cindy Zhang; Yi He; Jia Zhan; Michael H Bauman; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

Review 9.  Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease.

Authors:  Sreemanti Basu; Bonnie N Dittel
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

10.  Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Authors:  Ellen Andrag; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.